US Patent Issued to Arrowhead Pharmaceuticals on Dec. 23 for "RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of use" (Wisconsin, California Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,696, issued on Dec. 23, was assigned to Arrowhead Pharmaceuticals Inc. (Pasadena, Calif.).

"RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of use" was invented by Michelle Ngai (Fitchburg, Wis.), Feng Liu (Valley Center, Calif.), Puhui Li (San Diego), Xiaokai Li (San Diego), Zhi-Ming Ding (Waunakee, Wis.), Tao Pei (Middleton, Wis.), Daniel Braas (Madison, Wis.), So Wong (Oregon, Wis.), James C. Hamilton (Sierra Madre, Calif.) and Grigoriy Shekhtman (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to RNAi agents, e.g., double stranded ...